webinar register page

Webinar banner
2021 STI Treatment Guidelines—What does the laboratory need to know?
In July 2021 the Centers for Disease Control and Prevention published an update to the sexually transmitted infections Treatment Guidelines including diagnostic considerations for a number of sexually transmitted infections. Come hear what is new and how it may impact your current or future testing. Speakers will address topics such as testing for Mycoplasma genitalium and detection of antimicrobial resistance markers, numerous testing needs for Neisseria gonorrhoeae including test of cure as well as a two-step algorithm for herpes simplex virus testing.

Dec 8, 2021 11:00 AM in Eastern Time (US and Canada)

* Required information
Loading
By registering for this event, you are consenting to have your information shared with APHL event stakeholders, such as the Centers for Disease Control and Prevention and Public Health Labs. We will not, in any circumstances, share your information with other individuals or organizations without your permission, including corporations or individuals, except when applicable by law. We do not sell, communicate or divulge your information to any mailing lists.

Speakers

Laura Hinkle Bachmann, MD, MPH, FIDSA
chief medical office, division of STD prevention @CDC
Dr. Bachmann is Chief Medical Officer of the CDC Division of STD Prevention. Boarded in Internal Medicine and Infectious Diseases, Dr. Bachmann specializes in STD and HIV care with experience practicing in academic and public health settings. Dr. Bachmann’s Clinical Team led the development of CDC’s Recommendations for Providing Quality STD Clinical Services, 2020 and the 2021 CDC STI Treatment Guidelines.
Lindley Barbee, MD, MPH
associate professor, infectious diseases, University of Washington; medical consultant, division of STD prevention, CDC
Dr. Barbee is an infectious disease physician, specializing in bacterial sexually transmitted infections, who works at the intersection of academics and public health. Her research centers on clinical and epidemiological aspects of the prevention and control of sexually transmitted disease, with a particular focus on gonorrhea at the pharynx and rectum. Her current research explores STD self-testing, the natural history of gonorrhea and chlamydia at the pharynx and the rectum, and new treatments for antimicrobial resistant gonorrhea. She also puts research into practice as the Deputy Director of Public Health - Seattle & King County (PHSKC) HIV/STD Program, Medical Director of the PHSKC Sexual Health Clinic and Medical Consultant for CDC's Division of STD Prevention Clinical Team.
Christine Johnston, MD, MPH
associate professor, division of allergy & infectious diseases @University of Washington
Christine Johnston is a clinical virologist who has been studying the natural history and immunology of genital HSV infection for over 15 years with a goal to improving diagnostics and therapeutics for this chronic infection. She has expertise with managing herpes virus infections and was the subject matter expert for HSV for the 2021 STI Treatment Guidelines. In addition, she is the Medical Director for the University of Washington STD Prevention Training Center, part of the CDC-funded National Network of STD Prevention Training Centers.
Evelyn Nash, PhD
gonorrhea clinical activities unit lead, division of STD prevention @CDC
Evelyn Nash has a PhD in Microbiology and is the Unit Lead of the Gonorrhea Clinical Activities Unit at CDC. She oversees STD diagnostic testing for gonorrhea, chlamydia, trichomoniasis, and Mycoplasma genitalium infection. Her unit is also validating molecular assays to detect antimicrobial resistance markers in N. gonorrhoeae.
Brian H. Raphael, PhD
lead, gonorrhea, chlamydia, and M. genitalium team, division of STD prevention @CDC
Brian Raphael leads the Gonorrhea, Chlamydia and Mycoplasma genitalium Team in the STD Laboratory Reference and Research Branch at CDC. The team conducts STD diagnostic test development, antimicrobial susceptibility testing, and works to implement whole genomic sequencing for gonorrhea to support public health programs.